Advertisement

Topics

Latest "Perella Weinberg Partners" News Stories

07:04 EDT 17th July 2019 | BioPortfolio

Here are the most relevant search results for "Perella Weinberg Partners" found in our extensive news archives from over 250 global news sources.

More Information about Perella Weinberg Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Perella Weinberg Partners for you to read. Along with our medical data and news we also list Perella Weinberg Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Perella Weinberg Partners Companies for you to search.

Showing "Perella Weinberg Partners" News Articles 1–25 of 3,700+

Wednesday 17th July 2019

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the Australian Therapeutic Goods Administration to commercialize its CorPath® GRX System for neurovascular interventions in Australia and New Ze...


CO.DON AG: Negotiations with Xintela on creation of joint venture to be discontinued

DGAP-News: CO.DON AG / Key word(s): Strategic Company Decision 17.07.2019 / 10:33 The issuer is solely responsible for the content of this announcement. CO.DON: Negotiations with Xintela on creation of joint venture to be discontinued Berlin / Teltow, 17 July 2019 - As announced today in an ad hoc announcement, the negotiations announced on 9 July 2018 with the Swedish company Xintela...

Karus Therapeutics Strengthens Clinical Leadership Team with Appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer

Oxfordshire, UK – 17 July 2019 – Karus Therapeutics Ltd (‘Karus’), a clinical-stage biopharmaceutical company developing precision medicines for cancer, today announced the appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer (CMO) with immediate effect. Dr McElwaine-Johnn is a Physician with over 25 years’ experience in drug development, most ...


Harbour Antibodies Partners with Abveris, a Boston Drug Discovery CRO

Harbour Antibodies, the Dutch drug discovery subsidiary of Harbour BioMed, partnered with Boston's Abveris to offer its fully-human antibody discovery services together with Abveris' therapeutic antibody discovery services. Under a Co-Offering Agreement, Averis will be able to offer clients a low-upfront evaluation fee and pre-negotiated commercial terms. This will allow Abveris clients to conside...

Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome

Ann Arbor, Michigan July 16, 2019 – Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome. Arbor has an ongoing collaboration with the International Wheat Genome Sequencing Consortium (IWGSC), an international organization ded...

Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics

Financing proceeds to fund further platform development and therapeutic discovery in cancer and rare diseases, and expansion of Orum’s new Boston R&D labs Orum Therapeutics announced today an oversubscribed $30 million Series B financing. New investors, IMM Investment, Smilegate Investment, KTB Network, and Stassets Investment, join existing investors, InterVest and KB Investment/Solidus I...

Tuesday 16th July 2019

Eye Surgery Associates Enters Strategic Partnership With Eyecare Services Partners

Eye Surgery Associates (“ESA”), one of the leading comprehensive eye care providers in South Florida, has entered into a strategic partnership with Eyecare Services Partners Management, LLC (“ESP”), the leading national provider of integrated eye care services, effective July 15. This is the second such transaction in the last 60 days as ESP continues to build on its leadership in compreh...

Capital Rx Lands $12M To Redefine The $550B Pharmacy Benefit Industry

Capital Rx, a New York-based pharmacy benefits manager overseeing prescription benefit plans for employers, unions, and government entities, today announced it has raised $12M in growth funding led by Edison Partners. Transforming An Outdated Model “Historically, the PBM industry chose consolidation over innovation, which is why the model hasn’t evolved in twenty years,” said AJ Loiacono, ....

Redox Partners With Georgia’s Tech Incubator to Help Health IT Startups Scale

Healthcare interoperability provider Redox, today announced it has partnered with Advanced Technology Development Center (ATDC), Georgia’s technology incubator, to help health technology startups scale their business. Startups in ATDC’s HealthTech Program get access to Redox’s full-service integration platform. By working with Redox, startups in the program can overcome the industry&...

Frelii, Inc. Opens its First Subsidiary in Canada

Frelii, Inc. (OTC PINK: FRLI) (“Frelii” or “the Company") has opened a new wholly owned subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada, making it the Company’s first subsidiary supporting the Lehi, Utah headquarters. Frelii Canada will be led by Sandy Uppal, Chief Administrative Officer at Frelii and supported by Yvan Aubin, Executive Vice President of Finance at Frelii. ...

Too Much Smartphone Time May Invite Host of Health Woes

TUESDAY, July 16, 2019 -- With most people never far from their cellphones, new research on college students finds that "problematic" use is tied to a variety of mental health problems, as well as lower grades and more sexual partners. The study,...

Virginia Beach Sheriff’s Office and NaphCare Roll out New Opioid Detox Protocol Saving Lives in City Jail

NaphCare, Inc., a leading correctional healthcare provider, and the Virginia Beach Sheriff’s Office today announced the roll-out of an advanced protocol to proactively treat opioid withdrawal within the Virginia Beach Correctional Center. The new approach provides tapered administration of an opioid treatment medication called buprenorphine to assist patients with severe and sometimes life-thre...

Empyrean Partners with SAVVI Financial to Engage and Empower Employees by Connecting Financial Guidance with Benefit Decisions

Empyrean Benefit Solutions, Inc., the Hi-Touch Benefits Administration company, announced a strategic partnership with SAVVI Financial LLC, a leading technology-enabled financial wellness platform, to provide personalized, analytics-driven financial planning and management resources. SAVVI is fully integrated within Empyrean’s benefits enrollment and administrative platform, which serves more...

Optimal Just-in-Time Service Changing the Paradigm of Cancer Trials

First-patient-in milestone achieved in only two weeks with Cancer Treatment Centers of America Optimal Just-in-Time, a service of PPD’s Accelerated Enrollment

Surgical Case Coordination Pioneer Casetabs Receives $3 Million in Funding

Breakthrough Application Solves Case Coordination Issues, Improves Case Volume and Patient Satisfaction Casetabs, the innovator of cloud-based surgery coordination technology, today announced it has received $3 million in financing to further advance its surgery coordination application. The funding will be used to accelerate growth, further increase the application’s value to customers, and e...

Merck Partners with INROADS to Launch College Links

SOURCE: Merck & Co., Inc. DESCRIPTION:Merck hosted the next generation of talent recently when a group of high school students toured the company’s Kenilworth site as part of the INROADS College Links program. Merck partnered with INROADS, an international nonprofit organization that prepares talented, diverse youth for corporate and community leadership, to launch College Links in Newark, ...

Tishman Speyer and Bellco Capital Launch Breakthrough Properties, a First-of-Its-Kind Global Life Sciences Real Estate Platform

Unique Collaboration Combines First-Hand Biotechnology Entrepreneurship and Scientific Research Experience with Unsurpassed Commercial Real Estate Development Capabilities Newly-Formed Joint Venture Acquires its First Development Site, in Boston’s Seaport District Tishman Speyer, one of the world’s leading developers, owners, operators and asset managers of first-class real estate, and Be...

Delaware Innovation Space Launches an Entrepreneurial Advisory Council

Leaders from across the United States join forces with the Delaware Innovation Space to assist science startups The Delaware Innovation Space is proud to announce the formation of the Entrepreneurial Advisory Council (the EAC) for the Delaware Innovation Space and is pleased to introduce its foundational class which includes the following experts with diverse perspectives from across the country...

Roche partners with Sosei Heptares to develop drugs that modulate GPCR targets https://www.firstwordpharma.com/node/1653183  $RHHBY

Roche partners with Sosei Heptares to develop drugs that modulate GPCR targets https://www.firstwordpharma.com/node/1653183  $RHHBY

Oncimmune enters distribution deal for lung cancer assay in Spain

A new pact will expand distribution of Oncimmune's EarlyCDT Lung cancer assay in Spain after one of its distribution partners -More- 

Brian Gannon Joins Tower MSA Partners as Senior Vice President of Business Development

Tower MSA Partners has announced that Brian J. Gannon, MBA, ARM is its new Senior Vice President of Business Development. A member of Tower’s senior leadership team, he pursues new business opportunities, works with risk management teams to establish effective, proactive Medicare Secondary Payer compliance programs, and demonstrates Tower’s aggressive cost-saving solutions to insurance carrie...

Cullinan Oncology partners with MAB Discovery

Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic Tests in the Middle East and Africa

Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 -- Inivata, a leader in liquid biopsy, has signed a distribution agreement with IPS Genomix, part of the IPS Group,  to provide cancer patients and partners in the Middle East and Africa with access to its InVisionFirst®-Lung and InVisionSeq™ liquid biopsy tests.

AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare Proceeds to be used for the 1,400-patient international pivotal Phase III trial of recombinant human Alkaline Phosphatase (recAP) in patients with sepsis-associated acute kidney injury (SA-AKI)...

Illumina Expands Genomics Accelerator to Cambridge, UK

Partners with leading European venture capital firms to build breakthrough genomics startups Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Illum...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks